Local facts

Novo Nordisk has been operating in the UK for more than 25 years.  The UK is part of the business area called Europe North.  Europe North is responsible for approximately 25% of Novo Nordisk European sales and 12% of worldwide sales.

Therapy area breakdown
Within Europe North, diabetes care accounts for almost 80% of our business. Growth hormone therapy and hormone replacement therapy account for approximately 5% of our business each, and haemostasis management accounts for over 11% of our business.

Headquarters
With headquarters in Crawley, West Sussex, Novo Nordisk in the UK employs approximately 281 people.

Offshoring
Novo Nordisk Limited offshores its accounts payable processing.

Managing director
The managing director for the UK organisation is Mr Viggo Birch, vice president for Europe North.

_PA09006